Business Description
Medpace Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US58506Q1094
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.99 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | 0.36 | |||||
Interest Coverage | 241.12 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 8.26 | |||||
Beneish M-Score | -2.89 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.1 | |||||
3-Year EBITDA Growth Rate | 32.1 | |||||
3-Year EPS without NRI Growth Rate | 32.6 | |||||
3-Year FCF Growth Rate | 27.4 | |||||
3-Year Book Growth Rate | -7.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 17.91 | |||||
Future 3-5Y Total Revenue Growth Rate | 15.65 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.36 | |||||
9-Day RSI | 54.55 | |||||
14-Day RSI | 53.25 | |||||
6-1 Month Momentum % | 50.14 | |||||
12-1 Month Momentum % | 118.3 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.78 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.43 | |||||
Days Sales Outstanding | 46.99 | |||||
Days Payable | 8.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 4.7 | |||||
Shareholder Yield % | 0.19 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 27.99 | |||||
Operating Margin % | 18.07 | |||||
Net Margin % | 15.92 | |||||
FCF Margin % | 24.12 | |||||
ROE % | 64.05 | |||||
ROA % | 20.18 | |||||
ROIC % | 17.85 | |||||
ROC (Joel Greenblatt) % | 136.84 | |||||
ROCE % | 54.01 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 40.53 | |||||
Forward PE Ratio | 37.17 | |||||
PE Ratio without NRI | 40.53 | |||||
Shiller PE Ratio | 103.26 | |||||
Price-to-Owner-Earnings | 29.33 | |||||
PEG Ratio | 1.56 | |||||
PS Ratio | 6.64 | |||||
PB Ratio | 18.35 | |||||
Price-to-Free-Cash-Flow | 32.88 | |||||
Price-to-Operating-Cash-Flow | 25.73 | |||||
EV-to-EBIT | 34.87 | |||||
EV-to-Forward-EBIT | 30.88 | |||||
EV-to-EBITDA | 32.37 | |||||
EV-to-Forward-EBITDA | 28.67 | |||||
EV-to-Revenue | 6.29 | |||||
EV-to-Forward-Revenue | 5.5 | |||||
EV-to-FCF | 26.08 | |||||
Price-to-Projected-FCF | 2.8 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.62 | |||||
Earnings Yield (Greenblatt) % | 2.87 | |||||
FCF Yield % | 3.84 | |||||
Forward Rate of Return (Yacktman) % | 22.09 |